|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun X, Liu K, Lu S, He W and Du Z:
Targeted therapy and immunotherapy for heterogeneous breast cancer.
Cancers (Basel). 14:54562022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu W, Yang B, Yang L, Kaur J, Jessop C,
Fadhil R, Good D, Ni G, Liu X, Mosaiab T, et al: Therapeutic
effects of ten commonly used chinese herbs and their bioactive
compounds on cancers. Evid Based Complement Alternat Med.
2019:60578372019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang D, Fu Z, Xing Y, Tan Y, Han L, Yu H
and Wang T: Rapid identification of chemical composition and
metabolites of Pingxiao capsule in vivo using molecular networking
and untargeted data-dependent tandem mass spectrometry. Biomed
Chromatogr. 34:e48822020. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yao Q, Zhai H, Huang H, Lin J and He W: A
comparative study of the efficacy of tamoxifen and Chinese patented
medicine (Pingxiao capsules) in gynecomastia: A retrospective
cohort study. Andrologia. 54:e146402022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gradishar W and Salerno KE: NCCN
guidelines update: Breast cancer. J Natl Compr Canc Netw. 14 (5
Suppl):S641–S644. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Theriault RL, Carlson RW, Allred C,
Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano
SH, Goldstein LJ, et al: Breast cancer, version 3.2013: Featured
updates to the NCCN guidelines. J Natl Compr Canc Netw. 11:753–761.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen AP, Setser A, Anadkat MJ, Cotliar J,
Olsen EA, Garden BC and Lacouture ME: Grading dermatologic adverse
events of cancer treatments: The common terminology criteria for
adverse events version 4.0. J Am Acad Dermatol. 67:1025–1039. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou P: Traditional Chinese medicine. Comb
Chem High Throughput Screen. 13:8362010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu J, Mao JJ, Wang XS and Lin H:
Evaluation of traditional Chinese medicine herbs in oncology
clinical trials. Cancer J. 25:367–371. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Telang NT: Natural products as drug
candidates for breast cancer (review). Oncol Lett. 26:3492023.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang L, Hao J and Chen D: Role of
oxidative stress in anti-cancer activity of Tripterygium
wilfordii. Tradit Med Res. 6:502021. View Article : Google Scholar
|
|
13
|
Barreto C and Jandus A: Role of natural
products in combating cancer. Cancer Insight. 1:35–52. 2022.
|
|
14
|
Arzi L, Mollaei H and Hoshyar R:
Countering triple negative breast cancer via impeding Wnt/β-catenin
signaling, a phytotherapeutic approach. Plants (Basel).
11:21912022.PubMed/NCBI
|
|
15
|
Yang Z, Zhang Q, Yu L, Zhu J, Cao Y and
Gao X: The signaling pathways and targets of traditional Chinese
medicine and natural medicine in triple-negative breast cancer. J
Ethnopharmacol. 264:1132492021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zulfiker AH, Hashimi SM, Good DA, Grice ID
and Wei MQ: Cane toad skin extract-induced upregulation and
increased interaction of serotonin 2A and D2 receptors via Gq/11
signaling pathway in CLU213 cells. J Cell Biochem. 118:979–993.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He G, Mu T, Yuan Y, Yang W, Zhang Y, Chen
Q, Bian M, Pan Y, Xiang Q, Chen Z and Sun A: Effects of notch
signaling pathway in cervical cancer by curcumin mediated
photodynamic therapy and its possible mechanisms in vitro and in
vivo. J Cancer. 10:4114–4122. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abe M, Iihara H and Aogi K: Fosnetupitant
for the prevention of chemotherapy-induced nausea and vomiting: A
short review and clinical perspective. Adv Ther. 40:1913–1925.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gascón P, Awada A, Karihtala P, Lorenzen S
and Minichsdorfer C: Optimal use of granulocyte colony-stimulating
factor prophylaxis to improve survival in cancer patients receiving
treatment: An expert view. Wien Klin Wochenschr. Nov 27–2023.(Epub
ahead of print). PubMed/NCBI
|
|
21
|
Kuchuk I, Bouganim N, Beusterien K,
Grinspan J, Vandermeer L, Gertler S, Dent SF, Song X, Segal R,
Mazzarello S, et al: Preference weights for chemotherapy side
effects from the perspective of women with breast cancer. Breast
Cancer Res Treat. 142:101–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun CC, Bodurka DC, Weaver CB, Rasu R,
Wolf JK, Bevers MW, Smith JA, Wharton JT and Rubenstein EB:
Rankings and symptom assessments of side effects from chemotherapy:
Insights from experienced patients with ovarian cancer. Support
Care Cancer. 13:219–227. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ge A, Yang K, Deng X, Zhao D, Ge J and Liu
L: The efficacy and safety of Xihuang Pill/capsule in adjuvant
treatment of breast cancer: A systematic review and meta-analysis
of 26 randomized controlled trials. J Ethnopharmacol.
295:1153572022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peng W, Xu Y, Feng F, Gu C, Wang Z, Han D,
Zhou X and He H: Meta-analysis of therapy of cinobufacini capsule
adjunct with first-line platinum-based chemotherapy for the
treatment of advanced NSCLC. Evid Based Complement Alternat Med.
2021:55964152021. View Article : Google Scholar : PubMed/NCBI
|
